Formula Growth’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $870K | Hold |
27,000
| – | – | 0.39% | 90 |
|
|
2025
Q4 | $1.14M | Hold |
27,000
| – | – | 0.44% | 90 |
|
|
2025
Q3 | $927K | Hold |
27,000
| – | – | 0.33% | 99 |
|
|
2025
Q2 | $730K | Hold |
27,000
| – | – | 0.28% | 103 |
|
|
2025
Q1 | $801K | Hold |
27,000
| – | – | 0.32% | 100 |
|
|
2024
Q4 | $1.07M | Hold |
27,000
| – | – | 0.36% | 93 |
|
|
2024
Q3 | $919K | Hold |
27,000
| – | – | 0.32% | 93 |
|
|
2024
Q2 | $585K | Hold |
27,000
| – | – | 0.21% | 101 |
|
|
2024
Q1 | $598K | Hold |
27,000
| – | – | 0.19% | 107 |
|
|
2023
Q4 | $743K | Hold |
27,000
| – | – | 0.24% | 116 |
|
|
2023
Q3 | $603K | Sell |
27,000
-15,000
| -36% | -$386K | 0.21% | 120 |
|
|
2023
Q2 | $1.07M | Hold |
42,000
| – | – | 0.34% | 94 |
|
|
2023
Q1 | $937K | Hold |
42,000
| – | – | 0.3% | 102 |
|
|
2022
Q4 | $997K | Hold |
42,000
| – | – | 0.28% | 97 |
|
|
2022
Q3 | $697K | Hold |
42,000
| – | – | 0.2% | 110 |
|
|
2022
Q2 | $836K | Hold |
42,000
| – | – | 0.23% | 106 |
|
|
2022
Q1 | $1.16M | Sell |
42,000
-10,000
| -19% | -$286K | 0.22% | 111 |
|
|
2021
Q4 | $2.14M | Hold |
52,000
| – | – | 0.38% | 83 |
|
|
2021
Q3 | $2.42M | Hold |
52,000
| – | – | 0.35% | 85 |
|
|
2021
Q2 | $2.08M | Hold |
52,000
| – | – | 0.29% | 101 |
|
|
2021
Q1 | $2.79M | Sell |
52,000
-5,000
| -9% | -$288K | 0.4% | 75 |
|
|
2020
Q4 | $2.79M | Sell |
57,000
-18,000
| -24% | -$834K | 0.47% | 60 |
|
|
2020
Q3 | $2.44M | Hold |
75,000
| – | – | 0.46% | 61 |
|
|
2020
Q2 | $1.94M | Hold |
75,000
| – | – | 0.33% | 80 |
|
|
2020
Q1 | $1.82M | Hold |
75,000
| – | – | 0.35% | 67 |
|
|
2019
Q4 | $2.09M | Sell |
75,000
-5,000
| -6% | -$129K | 0.26% | 84 |
|
|
2019
Q3 | $1.92M | Hold |
80,000
| – | – | 0.29% | 82 |
|
|
2019
Q2 | $2.28M | Buy |
80,000
+5,000
| +7% | +$125K | 0.33% | 74 |
|
|
2019
Q1 | $1.88M | Hold |
75,000
| – | – | 0.27% | 86 |
|
|
2018
Q4 | $944K | Hold |
75,000
| – | – | 0.16% | 110 |
|
|
2018
Q3 | $716K | Buy |
+75,000
| New | +$827K | 0.08% | 133 |
|
|
2016
Q2 | – | Sell |
-64,785
| Closed | -$350K | – | 163 |
|
|
2016
Q1 | $350K | Sell |
64,785
-3,701
| -5% | -$21.9K | 0.08% | 147 |
|
|
2015
Q4 | $493K | Buy |
+68,486
| New | +$461K | 0.11% | 145 |
|
Other funds holding VCYT
VPM
VCM
AIM
Formula Growth's VCYT Position: Q1 2026 in Review
Formula Growth held its Veracyte (VCYT) position steady in Q1 2026 at 27,000 shares worth $870K. The position accounts for 0.39% of the portfolio, ranked #90.
Formula Growth first reported a position in VCYT in Q4 2015 and has held it in 33 quarters since. The position peaked at $2.79M in Q1 2021. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Formula Growth held 27,000 shares of Veracyte worth $870K as of Q1 2026.
- Formula Growth left its Veracyte share count unchanged in Q1 2026.
- Veracyte made up 0.39% of Formula Growth's portfolio in Q1 2026, its #90 holding.
- Formula Growth first reported a position in Veracyte in Q4 2015 and has held it in 33 quarters since.
- Formula Growth's Veracyte position peaked at $2.79M in Q1 2021.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Formula Growth's 13F filing for Q1 2026, filed 14 May 2026.